03.27.12
Marken has completed all commissioning work for its new operational hub in Feltham, UK. The 18,500-sq.-ft. facility is entirely occupied by Marken operational personnel and will serve as one of the company’s flagship facilities. The facility is equipped with space for product staging, re-icing, automatic scanning, quarantined goods, secure storage for dangerous goods, import and export operations and IT support. It will also have office space for the London branch operations, which has responsibility for all clients operating within the UK and Ireland.
The facility has 9000 sq. ft. of warehouse storage, 600 sq. ft. of controlled ambient storage, more than 1400 sq. ft. of secured and caged controlled substance storage, and more than 250 cubic feet of monitored walk-in cold and frozen storage space dedicated to support the life science industry.
“This new facility is in direct response to recent expansion requirements in the UK to support our growing client base,” said chief executive officer, Wes Wheeler. “We have designed this facility to accommodate all of the needs of the life science industry including inbound shipments of clinical samples and outbound shipments of drug product, active pharmaceutical ingredients and patient kits. We have allowed ample room for growth and for expanded services. We are very excited to be upgrading our facilities in the UK.”
The facility has 9000 sq. ft. of warehouse storage, 600 sq. ft. of controlled ambient storage, more than 1400 sq. ft. of secured and caged controlled substance storage, and more than 250 cubic feet of monitored walk-in cold and frozen storage space dedicated to support the life science industry.
“This new facility is in direct response to recent expansion requirements in the UK to support our growing client base,” said chief executive officer, Wes Wheeler. “We have designed this facility to accommodate all of the needs of the life science industry including inbound shipments of clinical samples and outbound shipments of drug product, active pharmaceutical ingredients and patient kits. We have allowed ample room for growth and for expanded services. We are very excited to be upgrading our facilities in the UK.”
